Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2011
09/14/2011CN102178720A Method for simultaneously preparing total saponin and polysaccharide from fiveleaf gynostemma herb
09/14/2011CN102178710A Method for preparing fissistigma total flavonoids and fissistigma total alkali
09/14/2011CN102178692A Compositions of hyaluronic acid and methods of use
09/14/2011CN102178691A Starch stypticum and preparation method thereof
09/14/2011CN102178679A Application of pyrroloquinoline quinone to the bone marrow hemopoietic function after recovery of radiation
09/14/2011CN102178654A Sustained-release microspheres and preparation method thereof
09/14/2011CN102178068A Application method of feed additive for lowering incidence rate of urinary calculi in sheep
09/14/2011CN101947247B Method for preparing ginkgodipyidamolum injection
09/14/2011CN101780229B Traditional Chinese medicine composition for treating gum bleeding and preparation method thereof
09/14/2011CN101780142B Leukogenic medicament containing lithium carbonate
09/14/2011CN101705218B Protease, preparation method of same, as well as application and pharmaceutical formulation thereof
09/14/2011CN101690764B Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof
09/14/2011CN101671341B Preparation method of iron chlorophyll extract
09/14/2011CN101549073B Medicament for treating idiopathic edema and preparation method thereof
09/14/2011CN101522688B Novel dithiolopyrrolones and their therapeutical applications
09/14/2011CN101514225B Self-polymerization polypeptide and preparation method and application thereof
09/14/2011CN101508993B Bullfrog lectin gene, encoded lectin and uses thereof
09/14/2011CN101455844B PEG-erythrocyte-stimulating factor and preparation method and use thereof
09/13/2011US8017726 Anti-inflammatory compounds and uses thereof
09/13/2011US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
09/13/2011US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/13/2011US8017628 Pharmaceutically active sulfonyl hydrazide derivatives
09/13/2011US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same
09/13/2011US8017125 Copolymers for suppression of autoimmune diseases, and methods of use
09/13/2011CA2524412C Medium and method for preserving platelets, red blood cells, and other non-nucleus cells and platelets-containing composition
09/13/2011CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
09/13/2011CA2472957C Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis
09/13/2011CA2469075C Pyrrolidine derivatives as prostaglandin modulators
09/13/2011CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/13/2011CA2428800C In vivo use of fluid absorbent polymers
09/13/2011CA2327587C Methods for treatment of haemophilia a patients using human anti-human fviii antibodies
09/13/2011CA2250792C Cocoa extract compounds and methods for making and using the same
09/09/2011WO2011109338A1 Methods and compositions for treating degos' disease
09/09/2011WO2011108963A1 Urethanes, ureas, amidines and related inhibitors of factor xa
09/09/2011WO2011084652A3 Crystalline salts of a factor xa inhibitor
09/09/2011CA2791962A1 Methods and compositions for treating degos' disease
09/09/2011CA2791875A1 Urethanes, ureas, amidines and related inhibitors of factor xa
09/08/2011US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof
09/08/2011US20110218209 Nutrient delievry drug composition
09/08/2011US20110218202 Soluble guanylate cyclase activators
09/08/2011US20110218169 Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia
09/08/2011US20110218162 15-thia steroid compounds and compositions
09/08/2011US20110218144 Method of Reducing Deleterious Effects of Ischemia-Reperfusion
09/08/2011US20110217394 Iridoid Based Formulations
09/08/2011US20110217393 Anti-fatigue composition
09/08/2011US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody
09/08/2011US20110217317 Treatment of thrombocytopenia
09/08/2011US20110217301 Methods for treating or screening for compounds for the treatment of sepsis
09/08/2011US20110217293 Uses of morelloflavone
09/08/2011US20110217284 Factor IX Variants with Clotting Activity in Absence of Their Cofactor and Their Use for Treating Bleeding Disorders
09/08/2011US20110217272 Treatment of radiation injury using placental stem cells
09/08/2011US20110217271 Treatment of diseases or disorders using placental stem cells
09/08/2011US20110217263 Expansion of haemopoietic precursors
09/08/2011US20110217259 IL-16 as a target for diagnosis and therapy of hematological malignancies and solid tumors
09/08/2011DE102009046115A1 Substituierte 3-Phenylpropansäuren und ihre Verwendung Substituted 3-Phenylpropansäuren and their use
09/07/2011EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody
09/07/2011EP2363405A1 Anti-infarction molecules
09/07/2011CN1990475B Substituted benzisoselenazolone compounds and use thereof
09/07/2011CN102177178A Anti-IL-12/IL-23 antibodies
09/07/2011CN102177137A 1-phenylpyrrole compounds
09/07/2011CN102176903A Iron source product in the form of capsules and process for their preparation
09/07/2011CN102176900A Pharmaceutical compositions and related methods of delivery
09/07/2011CN102174046A Tetomilast polymorphs
09/07/2011CN102174045A Tetomilast polymorphs
09/07/2011CN102172403A Method for treating interleukin-6 related diseases
09/07/2011CN102172389A Chinese medicinal preparation having functions of promoting digestion and improving growth and development
09/07/2011CN102172357A Core 2 glcnac-t inhibitors
09/07/2011CN101926826B Method for extracting active ingredients from sea horse
09/07/2011CN101836997B Glycerol/fructose composite and preparation method thereof
09/07/2011CN101791318B Novel application of bacterial lipopolysaccharides
09/07/2011CN101693014B Process for preparing coenzyme A medicament freeze drying preparation
09/07/2011CN101665465B Thrombase inhibitor containing guanidyl heterocyclic compound and preparation method thereof
09/07/2011CN101628101B Medicine combination and application thereof in preparing preparations for treating premature ovarian failure
09/07/2011CN101628091B Pharmaceutical composition for treating leukemia or aplastic anemia
09/07/2011CN101600431B Pharmaceutical composition having improved storage stability
09/07/2011CN101597337B Conjugate of hydroxyalkyl starch and an active agent
09/07/2011CN101580497B Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof
09/07/2011CN101559152B Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
09/07/2011CN101543626B Medicament for preventing and curing thrombus and preparation method thereof
09/07/2011CN101485858B Application of Chinese herbal medicine hirudo in cerebrovascular disease
09/07/2011CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof
09/07/2011CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection
09/07/2011CN101371847B Use of pseudo ginsengenin in preparing medicament for resisting platelet aggregation
09/07/2011CN101163716B Interleukin-6 polyethylene glycol conjugate and its preparing method and use
09/06/2011US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines
09/06/2011US8012996 Methods and composition for inhibition of angiogenesis
09/06/2011US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs
09/06/2011US8012728 Thrombin preparations and process for their production
09/06/2011US8012496 Gastric retention controlled drug delivery system
09/06/2011US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders
09/06/2011CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2011WO2011105611A1 Ghrelin receptor agonist for treatment of dyscrasia
09/01/2011WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions
09/01/2011US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
09/01/2011US20110213018 Compositions and methods for regulation of smooth muscle cells and blood pressure
09/01/2011US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c
09/01/2011US20110212983 Platelet adp receptor inhibitors
09/01/2011US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof
09/01/2011US20110212953 Polymorph Form II of Tanaproget
09/01/2011US20110212940 S1P Receptor Modulating Compounds and Use Thereof